Drugs panel to review applications for Covovax's use among kids aged 2-11 yrs

New Delhi: The topic professional committee on COVID-19 of India’s drug regulator will on Friday evaluate the functions of Serum Institute of India in search of emergency use authorisation to make use of Covovax amongst these aged 2-7 years and 7-11 years, official sources stated.

The 2 functions have been submitted by Prakash Kumar Singh, Director, Authorities and Regulatory Affairs at Serum Institute of India (SII), on March 16 and June 1.

Supply hyperlink

By Samy

Leave a Reply

Your email address will not be published.